ArticleFrontiers in cell and developmental biology2024

CRISPR-Cas9 screening develops an epigenetic and transcriptional gene signature for risk stratification and target prediction in neuroblastoma.

Liaoran Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.